Endotherm Publikationen

 2019

Mäder P: Boron in Medicinal Chemistry: Powerful, but Neglected.

Chimia 73 (2019) 637–638.

Kattner L, Rauch E: Recent developments towards the synthesis of vitamin D metabolites. Anticancer Res 2019;39:3280-3281.
2018     
Mohamed BA, Hartmann N, Tirilomis P, Sekeres K, Li W, Neef S, Richter C, Zeisberg EM, Kattner L, Didié M, Guan K, Schmitto JD, Lehnart SE, Luther S, Voigt N, Seidler T, Sossalla S, Hasenfuss G, Toischer K: Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression. Science Translational Medicine 2018;10:eaan0724. DOI: 10.1126/scitranslmed.aan0724
 2017     

Mohamed, BA, Kattner, L, Guan, K, Lehnart, SE, Luther, S, Sossalla, S, et al.: The relevant role of SR Ca leak in the development of heart failure. European Journal of Heart Failure 2017; 19(Suppl_1): 343-343.

Kattner L, Bernardi D: An Efficient Synthesis of 1,25-Dihydroxyvitamin D3 LC-Biotin. J Steroid Biochem Mol Biol. 2017;173:89-92.

Kattner L, Volmer DA: Synthesis of Low Abundant Vitamin D Metabolites and Assaying Their Distribution in Human Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as a New Tool for Diagnosis and Risk Prediction of Vitamin D related Diseases In: Gowder S, editor. A Critical Evaluation of Vitamin D - Basic Overview,  Intech publishers, Rijeka. 2017;103-127. ISBN 978-953-51-3084-0.

 2016      

Kattner L and Rauch E: Optimization of Chemical Syntheses of Vitamin D C3-Epimers
acrobat reader Anticancer Res 2016;36(3):1417-1422

 2015

Kattner L, Rauch E: Optimization of Chemical Syntheses of Vitamin D C3-Epimers
acrobat reader Anticancer Res 2015;35:3599-3614    

Kattner L, Bernardi D, Rauch E: Development of Efficient Chemical Syntheses of Vitamin D Degradation Products
acrobat reader Anticancer Res 2015;35(2):1205-1210

 2014

Azimi Hashemi N, Erbguth K, Vogt A, Riemensperger T, Rauch E, Woodmansee D, Nagpal J, Brauner M, Sheves M, Fiala A, Kattner L, Trauner D, Hegemann P, Gottschalk A & Liewald JF: Synthetic retinal analogues modify the spectral and kinetic characteristics of microbial rhodopsin optogenetic tools

acrobat reader Nature Communications 2014;(5):1-12

 2013

Sotoud H, Gribbon P, Ellinger B, Reinshagen J, Boknik P, Kattner L, El-Armouche A and Eschenhagen T: Development of a Colorimetric and a Fluorescence Phosphatase-Inhibitor Assay Suitable for Drug Discovery Approaches
acrobat reader J Biomol Screen 2013;18(8):899-909    

Bourgonje VJ, Vos MA, Ozdemir S, Doisne N, Acsai K, Varro A, Sztojkov-Ivanov A, Zupko I, Rauch E, Kattner L, Bito V, Houtman M, van der Nagel R, Beekman JD, van Veen TA, Sipido K, Antoons G:Combined Na+/Ca2+ Exchanger and L-Type Calcium Channel Block as a Potential Strategy to Suppress Arrhythmias and Maintain Ventricular Function
acrobat reader Circ Arrhythm Electrophysiol. 2013;6:371-379    

Scholz T, Heyl CL, Bernardi D, Zimmermann S, Kattner L,Klein CD: Chemical, Biochemical and Microbiological Properties of a Brominated Nitrovinylfuran with Broad-Spectrum Antibacterial Activity
acrobat reader Bioorg Med Chem, 2013;21:795-804

 2009

Steuer C, Heinonen KH, Kattner L, Klein CD: Optimization of Assay Conditions for Dengue Virus Protease: Effect of Various Polyols and Nonionic Detergents
acrobat reader J. Biomol Screen. 2009;14(9):1102-1108

 2008

Holzer M, Ziegler S, Albrecht B, Kronenberger B, Kaul A, Bartenschlager R, Kattner L, Klein CD, Hartmann RW: Identification of Terfenadine as an Inhibitor of Human
CD81-receptor HCV-E2 Interaction: Synthesis and Structure Optimization
acrobat reader Molecules. 2008;13:1081-1110

 2007

Kattner L: Outsourcing of medicinal chemistry in the drug discovery process faces CRO´s and pharmaceutical companies with challenges
acrobat reader PharmChem. 2007, July/August, 6-7